A three-year research programme has been launched at the Cyprus Institute of Neurology and Genetics (Cing) for the study and diagnosis of diseases with the use of the Next Generation DNA Sequencing technology, it announced on Tuesday.
The programme was made possible following a €180,000 donation by RCB Bank Ltd.
Speaking at the launch of the programme Chief Medical Director of Cing Leonidas Phylactou said the donation concerns research projects that use the Next Generation Sequencing DNA new technology which allows the detection of diseases which could otherwise only be diagnosed with great difficulty.
He added that the most important advantage of this innovative effort is the identification of the cause of the disease in a short period of time, with the focus on patients whose diagnosis was difficult until now. The detection includes cardiomyopathy, multiple sclerosis, drug-resistant cancer types, aneurysms and mitochondrial disorders.
Health Minister Giorgos Pamboridis said Cing has for 26 years been developing activities relating to the provision of high quality services but also education following the establishment of the School of Molecular Medicine. The institute, he said, carries out on average 45 projects per year with funding reaching €8m annually, while through its operations it provides multiple benefits to Cyprus as it enjoys international recognition.
Executive Director of RCB Bank Sotos Zacchaeus said it is with great pleasure that the bank supports the work of the institute which is synonymous with excellence in the fields of neurology, genetics and biomedical sciences and has been recognised in Europe and beyond.